Social factors related to the clinical severity of influenza cases in Spain during the A (H1N1) 2009 virus pandemic by Mayoral, José María et al.
Mayoral et al. BMC Public Health 2013, 13:118
http://www.biomedcentral.com/1471-2458/13/118RESEARCH ARTICLE Open AccessSocial factors related to the clinical severity of
influenza cases in Spain during the A (H1N1)
2009 virus pandemic
José María Mayoral1,17*, Jordi Alonso2,3, Olatz Garín2,3, Zaida Herrador4, Jenaro Astray5, Maretva Baricot3,
Jesús Castilla3,6, Rafael Cantón3,7, Ady Castro8, Miguel Delgado-Rodríguez3,9, Alicia Ferri3, Pere Godoy3,10,
Fernando Gónzález-Candelas3,11, Vicente Martín3,12, Tomás Pumarola13, José María Quintana3,14, Núria Soldevila3,
Sonia Tamames15, Ángela Domínguez3,16 and the CIBERESP Cases and Controls in Pandemic Influenza Working
Group, SpainAbstract
Background: During the 2009 influenza pandemic, a change in the type of patients most often affected by
influenza was observed. The objective of this study was to assess the role of individual and social determinants in
hospitalizations due to influenza A (H1N1) 2009 infection.
Methods: We studied hospitalized patients (cases) and outpatients (controls) with confirmed influenza A (H1N1)
2009 infection. A standardized questionnaire was used to collect data. Variables that might be related to the
hospitalization of influenza cases were compared by estimation of the odds ratio (OR) and 95% confidence intervals
(CI) and the variables entered into binomial logistic regression models.
Results: Hospitalization due to pandemic A (H1N1) 2009 influenza virus infections was associated with
non-Caucasian ethnicity (OR: 2.18, 95% CI 1.17 − 4.08), overcrowding (OR: 2.84, 95% CI 1.20 − 6.72), comorbidity and
the lack of previous preventive information (OR: 2.69, 95% CI: 1.50 − 4.83). Secondary or higher education was
associated with a lower risk of hospitalization (OR 0.56, 95% CI: 0.36 − 0.87)
Conclusions: In addition to individual factors such as comorbidity, other factors such as educational level, ethnicity
or overcrowding were associated with hospitalization due to A (H1N1) 2009 influenza virus infections.
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The pathogenesis of infectious diseases is generally well
known. Biomedical advances have resulted in a wide
understanding of the most common infectious agents.
However, individual and social factors also affect the
morbidity and mortality of infectious diseases and may
not be as easy to identify, measure or modify. These fac-
tors also seem to contribute to the differences in disease
incidence, evolution and severity detected between indi-
viduals and population groups [1-7].* Correspondence: josem.mayoral.sspa@juntadeandalucia.es
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and social resources influence the health status, regardless
of the health problems presented [8,9]. This relationship
has been widely studied, especially in the context of
chronic disease. However, applying this approach to acute
infectious diseases may be more difficult, for reasons
which include the short period of disease incubation and
duration and accessible, efficacious treatments [10,11].
After the A (H1N1) 2009 influenza virus pandemic,
some studies have analyzed the role of specific clinical
variables as risk factors for the development of severe in-
fluenza. However, studies on the 1918 pandemic point
to overcrowding and hunger as the main causes of the
rapid expansion of cases throughout Europe [12]. Al-
though individual factors such as nutrition, and thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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considered when studying influenza, there is sufficient
evidence of their impact on health and disease evolution
to warrant study of their possible role in severe cases of
influenza [13-16].
This is especially relevant in the case of A (H1N1) 2009
influenza virus infections, given the profile of severe cases
reported during the pandemic. A major epidemiological
difference between pandemic influenza virus A (H1N1)
2009 infections and previous seasonal influenza infections
was that the greatest proportion of severe cases occurred
in young people and young adults, resulting in an increase
in the potential life years lost [17-22]. However, the viru-
lence of the disease was particularly high among people
aged ≥ 65 years: while the incidence in the community was
low in this age group, the proportion of severe, hospita-
lized cases was higher. In Spain, it is estimated that 2.5%
of all cases of influenza attended by primary care centres
were in people aged ≥ 65 years, compared with 10.6%
admitted to hospital intensive care units [23].
Other determinants, such as differences in access to
preventive pharmacological and non-pharmacological
measures have also been show to play a role in infections
of acute onset [16,24]. Study of access to and the use of
health services may be valuable not only with respect to
the clinical evolution of cases but also in determining how
well they function in an atypical situation such as the 2009
pandemic [25-28]. Few studies of severe cases of influ-
enza have included non-clinical factors even though it
is known that vulnerability to infectious diseases is
mediated by individual and social conditions and that
these are a European public health priority [1,29]. The
aim of this study was to analyze individual and social
factors associated with hospitalization during the influ-
enza A (H1N1) 2009 pandemic.
Methods
Study design
We performed a multicenter matched case–control study.
Patients were recruited from hospitals and primary health-
care clinics and emergency units in seven Spanish regions
(Andalusia, Catalonia, Castile and Leon, Madrid, Navarre,
Basque Country and Valencia Community) between July
2009 and February 2010, during the peak of the influenza
A (H1N1) 2009 pandemic in Spain [24].
The sample size required to detect a relative risk (OR)
of 1.5 assuming a prevalence of the investigated factors
in outpatients of 0.15, a bilateral level of significance of
α = 0.05 and a power of β = 0.80 was 654, using the cri-
teria proposed by Schlesselman [30].
Selection of cases and controls:
Hospitalized cases were defined as all patients admitted
during the study period due to influenza-like illness, re-
spiratory infection (including pneumonia), septic shock ormultiple organ failure in whom pandemic influenza virus
A (H1N1) 2009 infection was confirmed. Nosocomial cases
were excluded.
For each hospitalized case, one control was identified
among patients attended by primary health care clinics
and emergency units due to influenza-like illness or re-
spiratory infection in whom A (H1N1) 2009 infection was
confirmed using the same diagnostic techniques as for
cases. Controls were matched with cases according to age
(±6 months in patients aged 0–2 years; ±3 years in
patients aged 3–17 years and ±5 years in patients aged >
17 years), date of hospitalization of the case (±21 days)
and province of residence of the case. If there was more
than one exact match, the control selected was the first
patient attended in an outpatient centre from the same
province as the hospitalized case whose sample was la-
boratory confirmed.
Exclusion criteria for cases and controls were failure
to answer the questionnaire and refusal of informed
consent.
Influenza virus A (H1N1) 2009 infection was confirmed
in cases and controls by real time RT-PCR. After giving
informed consent to participate in the study, cases and
controls were administered a structured questionnaire by
specifically-trained health professionals in order to collect
sociodemographic and medical information on unfavour-
able medical factors (smoking, morbid obesity [body
mass index (BMI) ≥ 40], hypertension, lung disease,
cardiovascular disease, kidney failure, diabetes, chronic
liver disease, immunodeficiency, disabling neurological
disease, malignancy, transplantation, cognitive dysfunc-
tion, seizure disorders and rheumatic diseases) and infor-
mation on preventive measures received through various
means (health centres, the media, internet, etc.) during the
previous year on preventing the spread of influenza and
antecedent of influenza pandemic vaccination. The social
variables of interest in this study were the educational
level, overcrowding (below the fifth percentile of the distri-
bution of square metres available per person in the normal
residence of all study participants), ethnicity and the use
of outpatient healthcare services, family physicians or
non-hospital emergency units due to influenza symptoms
in the 7 days before hospital admission in cases and a
medical visit due to influenza symptoms in controls.
Cases and controls were offered the possibility of com-
pleting the survey in person at a health centre or by
telephone.
The median time from hospitalization of cases or taking
the sample from outpatient controls until the survey was
calculated.
Statistical analysis
A descriptive analysis was made of the characteristics of
cases and controls. A bivariate analysis was made using
Table 1 Characteristics of matched cases (hospitalized
inpatients) and controls (outpatients) with confirmed
pandemic influenza A (H1N1) 2009
Characteristic Cases Controls
N (699) N (699)
Mean age (*) 37.82 33.69
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multivariate analysis was performed using binomial
logistic regression which included all variables of interest
and possible confounding factors. Associations were
measured using crude and adjusted odds ratios (OR)
and their 95% confidence intervals (CI).
The multivariate models were calculated using Cox
conditional logistic regression models.
Variables were selected manually and entered in an ini-
tial model that included all selected variables. Variables of
interest and significant variables in the bivariate analysis
were entered in the model. The probability of the steps for
entry was 0.05 and the output 0.10. The cutoff point for it-
eration was 0.5 and the maximum number of iterations
was 20. To assess whether this was an appropriate model,
the Wald statistic was calculated. The criterion for select-
ing a new model was determined by the coefficient of like-
lihood of the model. The analysis was made using the
SPSS v13.0 statistical package.
The variable age was included as a continuous variable
in order to adjust the multivariate model.Sex Male (*) 342 (49.1) 301 (43.1)
Female (*) 356 (50.9) 397 (56.9)
Ethnicity White (**) 588 (87.1) 634 (94.1)
Roma (**) 15 (2.2) 2 (0.3)
Amerindian (**) 46 (6.8) 16 (2.4)
Arab or North
African (*)
17 (2.5) 6 (0.9)
Other 10 (1.5) 18 (2.7)
Educational level No formal
education (**)
50 (7.7) 24 (3.7)
Primary (**) 213 (32.8) 128 (19.7)
Secondary 295 (45.4) 311 (47.8)
Higher (**) 92 (14.2) 187 (28.8)
Overcrowding > = 29 m2/p 234 (45.7) 252 (49.2)
28 - 15 m2/p 237 (46.3) 240 (47.1)
<= 14 m2/p (**) 41 (8) 20 (3.7)
Unfavourable medical
factors
0 (**) 242 (34.6) 382 (54.6)Data confidentiality and ethical considerations
All information collected was treated as confidential
according to the law on observational studies. The study
was approved by the Ethics Committee of the hospitals
involved (Clinical Research Ethics Committee, Hospital
Costa del Sol; Autonomous Clinical Trials Committee of
Andalusia; Clinical Research Ethics Committee, Clinica
de Leon; Clinical Research Ethics Committee, Municipal
Institute of Healthcare (CEIC-IMAS); Clinical Research
Ethics Committee, Corporación Sanitaria ParcTaulí of
Sabadell; Research Committee, Sant Joan de Déu Univer-
sity Hospital; Clinical Research Ethics Committee,
Basque Country; Clinical Research Ethics Committee,
Doctor Peset Univeristy Hospital, Valencia; and, Clinical
Research Ethics Committee, Clinical Research Ethics Com-
mittee, General Directorate of Public Health, Valencia.
Information was collected after written informed con-
sent was obtained from all patients.
1 230 (32.9) 238 (34)
2 (**) 122 (17.5) 58 (8.3)
>2 (**) 105 (15) 21 (3)
Prior preventive
information
Yes (**) 577 (82.5) 639 (91.4)
No (**) 122 (17.5) 60 (8.6)
Prior pandemic
vaccination
No 691 (99) 697 (99.9)
Yes 7 (1) 1 (0.1)
Previous outpatient
care
No (**) 357 (51.1) 557 (79.7)
Yes (**) 342 (48.9) 142 (20.3)
Previous emergency
care
No (**) 488 (69.8) 603 (86.3)
Yes (**) 211 (30.2) 96 (13.7)
(*) P <0.05, (**) p <0.01.Results
A total of 704 possible eligible hospitalized cases and 716
possible eligible controls were considered for the study.
Five hospitalized cases and eleven controls were excluded
because they did not give consent to participate and 6 pos-
sible eligible controls were excluded because failure to
response the questionnaire. So, finally a total of 699 cases
and 699 controls met the inclusion criteria and were
included in the analysis. Baseline characteristics of cases
and controls are shown in Table 1.
The median time from hospitalization of cases or taking
the sample from outpatient controls until the survey was99 days (range 0 to 404) for hospitalized cases and 155 days
(range 0 to 414) for outpatient controls.
No significant differences were found between sexes in
the proportion of hospitalized cases. A total of 87.1% of
cases and 94.1% of controls were Caucasian, 2.2% of cases
and 0.3% of controls were Roma (p = 0.002), 6.8% of cases
and 2.4% of controls were Amerindian (p <0.001) and
2.5% of cases and 0.9% of controls were Arab or North
African (p <0.05).
Significantly more cases had no (7.7%) or primary edu-
cation (32.8%) than controls (3.7% and 19.7% respectively,
p <0.001). In contrast 14.2% of cases and 28.8% of controls
had a higher education (p <0.001).
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had a living space of less than 14 m2. Significantly fewer
cases (34.6%) than controls (54.6%) had no risk factor or
comorbidity (p <0.001). In contrast, more cases than
controls had ≥ 2 risk factor (p < 0.001). Likewise, 17.5%
of cases but only 8.6% of controls had received no infor-
mation about preventing the transmission of influenza.
Visits to primary care or hospital emergency services in
the days before infection were significantly higher in
cases than in controls (p <0.001).
Table 2 shows the results of the bivariate and multivari-
ate analyses. No significant differences were found be-
tween sexes in the proportion of hospitalized cases.
Hospitalization was associated with non-Caucasian ethni-
city (Roma, Amerindian, Arab or North African) (OR
2.18, CI (95%): 1.17 − 4.08), and personal space < 14 m2
per person (OR: 2.84, 95% CI 1.20 − 6.72). Patients with
secondary or higher education had a lower probability of
hospitalization than patients without formal education or
with only primary education (OR: 0.56; 95% CI: 0.36-0.87).
Receiving information on preventive measures was a
protective factor against hospitalization. The probability of
hospitalization was higher in patients who had received no
information (OR: 2.69 95% CI: 1.50 − 4.83).
Hospitalization due to influenza increased according to
the number of risk factors and comorbidities (OR: 1.60,
95% CI: 1.07 − 2.40 for one, OR: 2. 94, 95% CI 1.61 − 5.36
for two and OR: 18.51, 95% CI 6.08 − 56.41 for ≥3 risk fac-
tors or comorbidities).
During the pandemic period, hospitalized cases made
more visits to primary care centres (OR 3.46, 95% CI
2.22 − 5.39) and outpatient emergency services (OR
2.68, 95% CI 1.66 − 4.32) compared with controls.
Discussion
The relationship between specific unfavourable medical
conditions and the severity of influenza infection has been
widely studied with respect to the 2009 pandemic
[23,31,32]. The number of comorbidities, which increases
with age, was an important factor in this respect, as shown
by other studies made of the pandemic [23,31]. The World
Health Organization working group on risk factors asso-
ciated with severe A (H1N1) 2009 virus infection found
that the proportion of cases with chronic disease increased
significantly in tandem with disease severity. The risk fac-
tors were similar to those of seasonal influenza, except for
differences related to age [32].
Spanish studies have found a greater frequency of
comorbidity in people aged ≥ 65 years, which was asso-
ciated with hospitalization [20,23]. Our results also show
that the probability of hospitalization increased in tandem
with the number of comorbidities, and that the influence
of these predisposing factors was independent of other
factors analysed.Various studies have shown a relationship between the
health status and social inequalities [2-7] that goes beyond
access to health services to include other factors such as
income, housing, education, ethnicity, etc., which may de-
termine the gradient of health between social groups
[33,34]. The present study assessed some of these factors,
including the educational level, ethnicity, overcrowding in
living conditions, and access to preventive information
and primary care services.
Given that influenza is transmitted aerially, overcrowd-
ing or workplace characteristics [35] or the use of public
transport [36] can also predispose to a greater risk of
exposure. Like other studies, we found a significant asso-
ciation between disease severity and a greater degree of
overcrowding, even with a threshold for overcrowding
that may be considered moderate [37]. Although we did
not find that this effect was modified by other factors
such as ethnicity or educational level, we suggest that
this association may be due to the relationship between
overcrowding and income levels, which influence disease
severity.
Spanish [38] and other [39,40] descriptive studies
show differences in the use of health services and in
hospitalization due to the complications of influenza
during the 2009 pandemic in immigrants and ethnic mi-
norities, on the one hand, and indigenous people on the
other hand. We found that non-Caucasian ethnicity was
associated with greater disease severity. Although the
small number of non-Caucasians included in the study
did not permit analysis by ethnic groups in the multi-
variate models. However, the descriptive statistics suggest
that greater disease severity occurred especially in Roma
and North African or South American immigrants.
Studies have shown that preventive measures, includ-
ing influenza vaccination, reduce mortality due to pneu-
monia and influenza in socially-deprived areas [16]. The
fact that more-highly educated people have a higher
socioeconomic level, have more information on avoiding
risks and more-easily access health services [41] for gen-
eral health care and for early care of other underlying
conditions that may worsen the severity of influenza,
may explain the association we found between lower
educational levels and disease severity.
We found that hospitalized patients more-frequently
attended primary care clinics and emergency units in
the days before the onset of influenza. This may be
related to the previous health status of hospitalized
patients. Because the Spanish health system has univer-
sal coverage, it seems unlikely that inequalities in access
to health care, as suggested by other authors [42], could
explain our results. Although the study design did not
permit assessment of the degree of compliance with pre-
ventive measures, people who had received preventive
information had fewer hospitalizations.
Table 2 Comparison of cases (hospitalized patients) and controls (outpatients) with confirmed pandemic influenza A
(H1N1) 2009
Independent variables Cases
(N = 699)
Controls
(N = 699)
Crude OR (95%) Adjusted OR (95%)
Sex Male 342 301 1 1
Female 356 397 0.79 (0.61 – 1.01) 0.72 (0.51 – 1.01)
Ethnicity White 588 634 1 1
Other 88 42 2.39** (1.45 – 3.98) 2.18** (1.17 – 4.08)
Educational level No/primary education 263 152 1 1
Secondary or higher 387 498 0.38** (0.27 – 0.53) 0.56** (0.36 – 0.87)
Overcrowding > = 29 m2 234 252 1 1
28 – 15 m2 237 240 1.07 (0.78 – 1.49) 1.09 (0.76 – 1.57)
<= 14 m2 41 20 3* (1.04 – 10.55) 2.84* (1.20 – 6.72)
Unfavourable medical factors 0 242 382 1 1
1 230 238 1.78** (1.25 – 2.53) 1.60* (1.07 – 2.40)
2 122 58 3.99** (1.99 – 8.03) 2.94** (1.61 – 5.36)
>2 105 21 38** (6.42 – 153.99) 18.51** (6.08 – 56.41)
Previous preventive information Yes 577 639 1 1
No 122 60 2.38** (1.56 – 3.66) 2.69** (1.50 – 4.83)
Prior pandemic vaccination No 691 697 1 1
Yes 7 1 – –
Previous outpatient care No 357 557 1 1
Yes 342 142 4.57** (3.23 – 6.51) 3.46** (2.22 – 5.39)
Previous emergency care No 488 603 1 1
Yes 211 96 3.02** (2.10 – 4.35) 2.68** (1.66 – 4.32)
Results of the bivariate analysis (crude OR) and conditional logistic regression (adjusted OR).
(*)P <0.05, (**) p <0.01.
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was not representative of the whole population infected,
as it was selected from patients who visited their family
physician for treatment for influenza. However, we be-
lieve this does not invalidate the results with respect to
the study objectives. Both cases and controls were asked
if they had received previous preventive information:
however, we do not know to what degree this informa-
tion was followed. However, given that we found signifi-
cant differences in the results between patients who did
and did not receive preventive information, the diffe-
rences may have been even greater in those patients who
did follow the advice given. Likewise, we were unable to
evaluate the effect of previous vaccination or early anti-
viral treatment due to the small number of study
patients who received these measures within the time
required to evaluate them, even though vaccination was
included in the adjusted analysis. The large number of
missing values found for the variable overcrowding was
assessed by comparing the characteristics of pairs with
and without information on this variable. We found no
significant differences, suggesting that the missing values
do not compromise the validity of the results. However,other social and environmental factors of interest may
not have been collected and analysed and therefore some
residual confounding cannot be ruled out.
Efforts to reduce the impact of social inequality on the
effects of communicable disease epidemics, such as in-
fluenza, must be undertaken not only by front-line health
care services but also by preventive services and non-
health care agents. Health interventions can reduce, but
not eliminate health inequalities, as other sociodemo-
graphic determinants are not susceptible to these inter-
ventions and require a multidisciplinary approach. The
adoption of plans and interventions that address the dif-
ferential demographic impact of influenza may help to
partially prevent the consequence of social inequalities on
disease outcomes [1,11]. However, awareness of the risk of
the “inverse care law” [43], that is, increased inequality
due to the higher social classes having better access to pre-
ventive interventions should also be heightened.
Conclusions
The main conclusions of this study are that, in addition
to individual factors such as pre-existing unfavourable
medical conditions, other social factors, such as non-
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ive measures, overcrowding, and a primary education or
less, increased the risk of hospitalization due to con-
firmed influenza.
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